ITMI20041255A1 - Sistemi microparticellari per somministrazione orale di sostanze biologicamente attive - Google Patents
Sistemi microparticellari per somministrazione orale di sostanze biologicamente attiveInfo
- Publication number
- ITMI20041255A1 ITMI20041255A1 ITMI20041255A ITMI20041255A1 IT MI20041255 A1 ITMI20041255 A1 IT MI20041255A1 IT MI20041255 A ITMI20041255 A IT MI20041255A IT MI20041255 A1 ITMI20041255 A1 IT MI20041255A1
- Authority
- IT
- Italy
- Prior art keywords
- oral administration
- biologically active
- active substances
- microparticle systems
- microparticle
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI20041255 ITMI20041255A1 (it) | 2004-06-22 | 2004-06-22 | Sistemi microparticellari per somministrazione orale di sostanze biologicamente attive |
PCT/IT2005/000353 WO2005123034A2 (fr) | 2004-06-22 | 2005-06-20 | Systemes de microparticules pour l'administration par voie orale de substances bioactives |
EP05760593A EP1778192A2 (fr) | 2004-06-22 | 2005-06-20 | Systemes de microparticules pour l'administration par voie orale de substances bioactives |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI20041255 ITMI20041255A1 (it) | 2004-06-22 | 2004-06-22 | Sistemi microparticellari per somministrazione orale di sostanze biologicamente attive |
Publications (1)
Publication Number | Publication Date |
---|---|
ITMI20041255A1 true ITMI20041255A1 (it) | 2004-09-22 |
Family
ID=35510243
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ITMI20041255 ITMI20041255A1 (it) | 2004-06-22 | 2004-06-22 | Sistemi microparticellari per somministrazione orale di sostanze biologicamente attive |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1778192A2 (fr) |
IT (1) | ITMI20041255A1 (fr) |
WO (1) | WO2005123034A2 (fr) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2991162A1 (fr) * | 2007-12-21 | 2009-07-02 | Aptevo Biotherapeutics Llc | Formulations stabilisees de facteur ix contenant du trehalose |
JP5724108B2 (ja) * | 2009-04-22 | 2015-05-27 | メドスキン ソリューションズ ドクター ズベラック アーゲーMedSkin Solutions Dr.Suwelack AG | 凍結乾燥組成物 |
PL2675287T3 (pl) | 2011-02-18 | 2017-01-31 | Dupont Nutrition Biosciences Aps | Kompozycja dodatku paszowego |
GB201102857D0 (en) | 2011-02-18 | 2011-04-06 | Danisco | Feed additive composition |
GB201102865D0 (en) | 2011-02-18 | 2011-04-06 | Danisco | Feed additive composition |
GB201213801D0 (en) | 2012-08-03 | 2012-09-12 | Dupont Nutrition Biosci Aps | Feed additive composition |
CN104735999A (zh) | 2012-08-03 | 2015-06-24 | 杜邦营养生物科学有限公司 | 饲料添加剂组合物 |
WO2015061618A1 (fr) * | 2013-10-23 | 2015-04-30 | Jessup Donald W | Formulation d'acide hyaluronique |
UA125639C2 (uk) | 2015-11-09 | 2022-05-11 | Дюпон Нутрішин Біосайнсес Апс | Композиція кормової добавки, спосіб її одержання, набір, корм та премікс, що містять композицію кормової добавки |
US20190000950A1 (en) | 2015-12-29 | 2019-01-03 | Intervet Inc. | Coccidiosis vaccine |
CN113115952A (zh) * | 2021-05-27 | 2021-07-16 | 江苏恒康生物科技有限公司 | 一种含微晶球的耐胃酸爆珠及其制备方法 |
US11833224B1 (en) | 2023-02-08 | 2023-12-05 | Leuvian Llc | Lyoprotectant compositions and uses thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR960011236B1 (ko) * | 1987-05-08 | 1996-08-21 | 스미스 클라인 앤드 프렌취 라보라토리스 리미티드 | 제약학적 조성물 및 고체 제형 |
US5230901A (en) * | 1988-03-23 | 1993-07-27 | Knoll Ag | Sustained release tablet of a mixture of alginates and polyacrylates |
US5876754A (en) * | 1992-01-17 | 1999-03-02 | Alfatec-Pharma Gmbh | Solid bodies containing active substances and a structure consisting of hydrophilic macromolecules, plus a method of producing such bodies |
US5695781A (en) * | 1995-03-01 | 1997-12-09 | Hallmark Pharmaceuticals, Inc. | Sustained release formulation containing three different types of polymers |
US6251430B1 (en) * | 1998-02-04 | 2001-06-26 | Guohua Zhang | Water insoluble polymer based sustained release formulation |
-
2004
- 2004-06-22 IT ITMI20041255 patent/ITMI20041255A1/it unknown
-
2005
- 2005-06-20 WO PCT/IT2005/000353 patent/WO2005123034A2/fr active Application Filing
- 2005-06-20 EP EP05760593A patent/EP1778192A2/fr not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO2005123034A2 (fr) | 2005-12-29 |
EP1778192A2 (fr) | 2007-05-02 |
WO2005123034A8 (fr) | 2006-03-30 |
WO2005123034A3 (fr) | 2006-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ITMI20052461A1 (it) | Sistemi microparticellari per la somministrazione orale di sostanze biologicamente attive | |
ATE380544T1 (de) | Umhüllte feste darreichungsform | |
DK1545662T3 (da) | Lægemiddelindgivelsessystem | |
DK1545467T3 (da) | Faste farmaceutiske formuleringer omfattende telmisartan | |
EP1631239A4 (fr) | Compositions pharmaceutiques contenant des composes actifs de vitamine d | |
ATE405630T1 (de) | Wirkstoffabgabesysteme | |
NO20043702L (no) | 8-azaprostaglandinderivatforbindelser og legemidler inneholdende forbindelsene som den aktive bestanddel | |
PT2985026T (pt) | Sistemas de distribuição farmacêuticos para fármacos hidrófobos e composições compreendendo os mesmos | |
DK1635875T3 (da) | In-situ-geldannende lægemiddeladministrationssystem | |
NO20052952D0 (no) | Farmasoytisk sammensetning som innbefatter mikropartikler | |
IL180031A0 (en) | Stable pharmaceutical formulations of benzimidazole compounds | |
HUE040600T2 (hu) | Állatgyógyászati gyógyszer-leadó készülék | |
DK1498411T3 (da) | Diketohydrazinderivatforbindelser og medikamenter indeholdende forbindelserne som den aktive bestanddel | |
IL229510A0 (en) | A dosage form containing pantoprazole as an active ingredient | |
DE602004011398D1 (de) | Direkt komprimierbare pharmazeutische zusammensetzung für die orale verabreichung von cci-779 | |
DK1837019T3 (da) | Orale dispergerbare farmaceutiske sammensætninger | |
ITMI20041255A1 (it) | Sistemi microparticellari per somministrazione orale di sostanze biologicamente attive | |
IL216104A0 (en) | Coated drug delivery formulations | |
EP1602362A4 (fr) | Composition de medicament comportant un principe actif adhere en concentration elevee a un noyau spherique | |
AU2003301444A1 (en) | System for delivery of active substances | |
NO20043576L (no) | Pharmaceutical formulation comprising melatonin | |
DE60321572D1 (de) | Transdermales arzneimittelverabreichungssystem | |
NO20043243L (no) | Legemiddelleveringssystem for vedvarende frigivelse av glipizid | |
IS7290A (is) | Lyfjasamsetningar sem innihalda risperidone | |
ATE455540T1 (de) | Orale dosierform für die kontrollierte arzneimittelfreisetzung |